Lv41
440 积分 2023-10-13 加入
Small Cell Lung Cancer: A Review
9小时前
待确认
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results
2个月前
已完结
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
3个月前
已完结
Exploring the next generation of antibody–drug conjugates
3个月前
已完结
Antibody–drug conjugates come of age in oncology
3个月前
已完结
HER2-targeted therapies beyond breast cancer — an update
3个月前
已完结
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
5个月前
已完结
Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small Cell Lung Cancer
5个月前
已完结
Facts and Hopes in Neoadjuvant Immunotherapy Combinations in Resectable Non–Small Cell Lung Cancer
5个月前
已完结
Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer
6个月前
已完结
皖公网安备34019202002308
